To examine whether depletion of HDAC6 can re-sensitize cisplatin resistant cells, C13 cell line, a cisplatin resistant ovarian cancer cell line derived from OV2008 [34], was stably transfected with control or HDAC6 shRNA to establish control and HDAC6 knockdown cell lines. This evidence concerns the gene HDAC6 and ovarian carcinoma.